In Situ Forming ROS-Scavenging Hydrogel with a STING Inhibitor Improves Recovery After Acute Spinal Cord Injury by Modulating Inflammatory Microenvironment.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41612749.
- Also identified by DOI 10.1002/adhm.202504534.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The inflammatory cascade initiated by acute spinal cord injury (SCI) is a crucial element contributing to subsequent pathological damage. Uncontrolled or excessive inflammatory responses aggravate neural tissue destruction and hinder the regenerative process. Stimulator of interferons genes (STING) is a key regulator in the innate immune signaling pathway that promotes the generation of inflammatory mediators by activating the TBK1 and IRF3 signaling pathways, thereby shaping the post-injury microenvironment. In this study, we developed a hyaluronic acid-phenylboronic acid-polyvinyl alcohol-based hydrogel (HA-PBA-PVA, termed HPP) as a local delivery vehicle for the STING-specific inhibitor C-176, which was applied directly to the injury epicenter in a rat model of complete spinal cord transection. The locally implanted C-176@HPP can effectively deliver C-176 to the injured site, markedly reducing the expression of pro-inflammatory cytokines by regulating the STING/TBK1 signaling pathway. Moreover, the administration of C-176@HPP can significantly attenuate microglial activation and promote neuronal survival and axonal regeneration, which eventually contribute to locomotor improvement after SCI. Our findings demonstrate that C-176@HPP provides a promising strategy for ameliorating neuro-inflammation and facilitating neural tissue regeneration after SCI.
Medical subject headings
- Spinal Cord Injuries
- Hydrogels
- Inflammation
- Membrane Proteins